本文翻译正在准备中。在此之前，我们暂时显示英文原文。
监管与法律 · 1996/9/191 分钟阅读
Sperti Drug Products, Inc., et al.; Withdrawal of Approval of 40 New Drug Applications
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is withdrawing 40 new drug applications (NDA's). The basis for the withdrawals is that the holders of the applications have repeatedly failed to file required annual reports on these NDA's.
来源原始语言: Federal Register — All Documents打开原始公告 →